MetaCap

Compugen Insider Trades

NASDAQ: CGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.84-0.04 (-2.13%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
12 · $126.29K
Shares bought / sold
0 / 51.00K
Net activity
Net selling $126,291

Compugen insider activity

Over the last 12 months, Compugen insiders reported 37 transactions on SEC Form 4: 0 open-market purchases and 12 sales. Insiders bought $0 and sold $126,291 worth of stock, for net insider selling of $126,291. The largest seller was Levine Zurit, with $83,357 in reported sales.

The most recent filing shows Levine Zurit (SVP, Business Development) reporting a transaction in 18,000 shares on Jul 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CGEN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CGEN insider transactions

Compugen insider transactions
DateInsiderTypeSharesValueFiling
Jul 29, 2026Mahler MichelleChief Medical OfficerAward13,500—Form 4
Jul 29, 2026ZWEIFACH SANFORD SDirectorAward7,500—Form 4
Jul 29, 2026Halevy GileadDirectorAward7,500—Form 4
Jul 29, 2026Hukkelhoven MathiasDirectorAward7,500—Form 4
Jul 29, 2026Livnat Savitzky KinneretDirectorAward7,500—Form 4
Jul 29, 2026Kredo Russo SharonSVP, Research & DiscoveryAward18,000—Form 4
Jul 29, 2026Perry EranDirectorAward7,500—Form 4
Jul 29, 2026Silberman DavidChief Financial OfficerAward19,500—Form 4
Jul 29, 2026Levine ZuritSVP, Business DevelopmentAward18,000—Form 4
Jul 9, 2026Levine ZuritSVP, Business DevelopmentSale1,875$4.69KForm 4
Jul 9, 2026Levine ZuritSVP, Business DevelopmentOption exercise1,875$1.55KForm 4
Apr 24, 2026Ophir EranPresident and CEOSale5,000$16.00KForm 4
Apr 24, 2026Ophir EranPresident and CEOOption exercise5,000$4.15KForm 4
Apr 24, 2026Levine ZuritSVP, Business DevelopmentSale2,000$6.40KForm 4
Apr 24, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,000$2.30KForm 4
Apr 14, 2026Ophir EranPresident and CEOSale5,000$14.52KForm 4
Apr 14, 2026Ophir EranPresident and CEOOption exercise5,000$4.15KForm 4
Apr 14, 2026Levine ZuritSVP, Business DevelopmentSale2,000$5.60KForm 4
Apr 14, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,000$2.30KForm 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentSale3,125$8.01KForm 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,000$2.30KForm 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentOption exercise1,125$932.85Form 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentSale3,125$8.01KForm 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,000$2.30KForm 4
Apr 10, 2026Levine ZuritSVP, Business DevelopmentOption exercise1,125$932.85Form 4
Apr 8, 2026Levine ZuritSVP, Business DevelopmentSale5,375$13.01KForm 4
Apr 8, 2026Levine ZuritSVP, Business DevelopmentOption exercise1,000$1.15KForm 4
Apr 8, 2026Levine ZuritSVP, Business DevelopmentOption exercise4,375$3.63KForm 4
Apr 7, 2026Levine ZuritSVP, Business DevelopmentSale2,500$5.75KForm 4
Apr 7, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,500$2.07KForm 4
Apr 1, 2026Ophir EranPresident and CEOSale5,625$12.41KForm 4
Apr 1, 2026Ophir EranPresident and CEOOption exercise5,625$4.66KForm 4
Apr 1, 2026Levine ZuritSVP, Business DevelopmentSale3,500$7.70KForm 4
Apr 1, 2026Levine ZuritSVP, Business DevelopmentOption exercise1,000$1.15KForm 4
Apr 1, 2026Levine ZuritSVP, Business DevelopmentOption exercise2,500$2.07KForm 4
Mar 26, 2026Levine ZuritSVP, Business DevelopmentSale11,875$24.19KForm 4
Mar 26, 2026Levine ZuritSVP, Business DevelopmentOption exercise11,875$9.85KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related